At the time of writing, Arcellx Inc [ACLX] stock is trading at $59.05, up 12.31%. An important factor to consider is whether the stock is rising or falling in short-term value. The ACLX shares have gain 6.76% over the last week, with a monthly amount drifted -0.39%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Arcellx Inc [NASDAQ: ACLX] stock has seen the most recent analyst activity on May 31, 2024, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $70. Previously, Morgan Stanley started tracking the stock with Overweight rating on March 07, 2024, and set its price target to $81. On January 04, 2024, Needham reiterated its Buy rating and revised its price target to $71 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $66 on December 19, 2023. TD Cowen initiated its recommendation with a Outperform. UBS started tracking with a Buy rating for this stock on October 17, 2023, and assigned it a price target of $52. In a note dated May 18, 2023, Truist initiated an Buy rating and provided a target price of $60 on this stock.
For the past year, the stock price of Arcellx Inc fluctuated between $30.88 and $75.10. Currently, Wall Street analysts expect the stock to reach $61 within the next 12 months. Arcellx Inc [NASDAQ: ACLX] shares were valued at $59.05 at the most recent close of the market. An investor can expect a potential return of 3.3% based on the average ACLX price forecast.
Analyzing the ACLX fundamentals
According to Arcellx Inc [NASDAQ:ACLX], the company’s sales were 144.75M for trailing twelve months, which represents an 91.47% jump. Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -0.56%, Pretax Profit Margin comes in at -0.37%, and Net Profit Margin reading is -0.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.12 and Total Capital is -0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 55.20 points at the first support level, and at 51.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 61.40, and for the 2nd resistance point, it is at 63.75.
Ratios To Look Out For
It is important to note that Arcellx Inc [NASDAQ:ACLX] has a current ratio of 6.01. On the other hand, the Quick Ratio is 6.01, and the Cash Ratio is 1.14. Considering the valuation of this stock, the price to sales ratio is 21.83, the price to book ratio is 6.50.
Transactions by insiders
Recent insider trading involved Heery Christopher, CHIEF MEDICAL OFFICER, that happened on Aug 01 ’24 when 20000.0 shares were sold. Director, Patel Kavita completed a deal on Jul 30 ’24 to sell 1500.0 shares. Meanwhile, CHIEF MEDICAL OFFICER Heery Christopher sold 10901.0 shares on Jul 16 ’24.
